1. Home
  2. AUID vs CVM Comparison

AUID vs CVM Comparison

Compare AUID & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.10

Market Cap

18.4M

Sector

Technology

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.05

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
CVM
Founded
2009
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
21.4M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
AUID
CVM
Price
$1.10
$1.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
107.9K
357.5K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
N/A
N/A
Revenue
$2,040,660.00
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
130.20
65.45
52 Week Low
$0.84
$0.89
52 Week High
$5.82
$13.48

Technical Indicators

Market Signals
Indicator
AUID
CVM
Relative Strength Index (RSI) 45.54 34.15
Support Level $0.93 $0.94
Resistance Level $1.13 $1.59
Average True Range (ATR) 0.09 0.11
MACD -0.01 0.03
Stochastic Oscillator 32.14 17.31

Price Performance

Historical Comparison
AUID
CVM

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: